The HIV-1 Antisense Gene ASP: the New Kid on the Block

Total Page:16

File Type:pdf, Size:1020Kb

The HIV-1 Antisense Gene ASP: the New Kid on the Block Review The HIV-1 Antisense Gene ASP: The New Kid on the Block Zahra Gholizadeh, Mohd. Shameel Iqbal, Rui Li and Fabio Romerio * Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; [email protected] (Z.G.); [email protected] (M.S.I.); [email protected] (R.L.) * Correspondence: [email protected] Abstract: Viruses have developed incredibly creative ways of making a virtue out of necessity, including taking full advantage of their small genomes. Indeed, viruses often encode multiple proteins within the same genomic region by using two or more reading frames in both orientations through a process called overprinting. Complex retroviruses provide compelling examples of that. The human immunodeficiency virus type 1 (HIV-1) genome expresses sixteen proteins from nine genes that are encoded in the three positive-sense reading frames. In addition, the genome of some HIV-1 strains contains a tenth gene in one of the negative-sense reading frames. The so-called Antisense Protein (ASP) gene overlaps the HIV-1 Rev Response Element (RRE) and the envelope glycoprotein gene, and encodes a highly hydrophobic protein of ~190 amino acids. Despite being identified over thirty years ago, relatively few studies have investigated the role that ASP may play in the virus lifecycle, and its expression in vivo is still questioned. Here we review the current knowledge about ASP, and we discuss some of the many unanswered questions. Keywords: HIV-1; natural antisense transcription; antisense protein (ASP); overprinting; replication; pathogenesis; spread Citation: Gholizadeh, Z.; Iqbal, M.S.; Li, R.; Romerio, F. The HIV-1 Antisense Gene ASP: The New Kid 1. Introduction: De Novo Creation of Genes on the Block. Vaccines 2021, 9, 513. In the majority of cases, new genes are created by transfer of existing genetic mate- https://doi.org/ rial [1]. This can occur in various forms: exon shuffling, gene duplication, retroposition, 10.3390/vaccines9050513 lateral gene transfer, and gene fusion or fission [1]. However, in rare cases, genes can also be created de novo. This mechanism was thought to be rare [2], but recent studies show that it Academic Editor: Mudit Tyagi occurs frequently. De novo gene creation can occur in intergenic regions and introns [3,4], but also in genomic regions that already contain a protein-coding gene—a process called Received: 20 April 2021 ‘overprinting’ (Figure1). In this case, a genomic region with an existing coding sequence in Accepted: 13 May 2021 one of the six reading frames (Figure1A) undergoes point mutations in one of the other Published: 17 May 2021 five reading frames that generate a new start codon (Figure1B) and/or remove stop codons (Figure1C), giving rise to a second coding sequence. The resulting genomic region contains Publisher’s Note: MDPI stays neutral two overlapping open reading frames (ORFs): the ancestral or ‘overprinted’ gene, and the with regard to jurisdictional claims in novel or ‘overprinting’ gene [5]. For most gene pairs, the identification of the ancestral published maps and institutional affil- and the de novo gene can be determined with high accuracy because the former presents a iations. much wider phylogenetic distribution than the latter [6]. Indeed, proteins that are created de novo by overprinting do not have homologs in other organisms and are at times referred to as taxonomically restricted or ‘ORFans’ [7,8]. However, it is also possible that de novo proteins may be members of a family of proteins that have diverged beyond recognition or Copyright: © 2021 by the authors. that were lost [9]. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). Vaccines 2021, 9, 513. https://doi.org/10.3390/vaccines9050513 https://www.mdpi.com/journal/vaccines Vaccines 2021, 9, x 2 of 15 Vaccines 2021, 9, 513 2 of 15 A. +3 +2 Ancestral gene +1 -1 -2 -3 Creation of start in +3 reading frame Removal of stop in -2 reading frame Novel/overprinting gene B.+3 C. +3 +2 +2 Ancestral/overprinted gene Ancestral/overprinted gene +1 +1 -1 -1 Novel/overprinting gene -2 -2 -3 -3 Figure 1. De novo creation of genes by overprinting. Typically, genomic regions contain a single gene encoding a protein Figureproduct 1. inDe one novo of creation the 6 reading of genes frames by overprinting. (for example, Typically, reading framegenomi +1c regions in panel contain (A). The a single same genomicgene encoding region a doesprotein not productencode anyin one protein of the in 6 the reading other 5frames reading (for frames, example, either reading because frame of absence +1 in panel of start (Acodons). The same (as in genomic reading frameregion +3 does and not−3, encodemarked any with protein×) or in because the other of the 5 readin presenceg frames, of stop eithers shortly because after aofstart absencecodon of (asstart in codons reading (as frames in reading +2, − 1frame and − +32, and marked −3, markedwith •). with The ×) occurrence or because of of single the presence point mutations of stops shortly in one ofafter these a start 5 reading codon frames(as in reading can give frames rise to +2, a new−1 and protein-coding −2, marked withgene, ●). either The byoccurrence creating aof new singlestart pointcodon mutati (as inons reading in one frame of these +3 5 in reading panel (B frames) or by can eliminating give rise a tostop a newcodon protein-coding (as in reading gene,frame either−2 in by panel creating (C). Whena new thisstart occurs, codon (as the in original reading gene frame is called +3 in panel ‘ancestral’ (B) or or by ‘overprinted’, eliminating a while stop codon the new (as one in reading is called frame‘novel’ −2 or in ‘overprinting’. panel (C). When In rare this cases,occurs, both the events original can gene occur is called over time ‘anc (asestral’ in the or case‘overprinted’, of HTLV-1 while and HIV-1), the new thus one giving is called rise ‘novel’ or ‘overprinting’. In rare cases, both events can occur over time (as in the case of HTLV-1 and HIV-1), thus giving to genomic regions that contain three overlapping protein-coding genes. rise to genomic regions that contain three overlapping protein-coding genes. 2.2. Overprinting Overprinting in in Viral Viral Genomes Genomes OverprintingOverprinting has has been been documented documented in both prokaryotic in both prokaryotic and eukaryotic and genomes eukaryotic [10– 17].genomes However, [10– the17]. incidence However, of the overlapping incidence ofge overlappingnes in these organisms genes in these is relatively organisms low is [18– rela- tively low [18–20]. On the other hand, overprinting is quite frequent in viral genomes [21, 20]. On the other hand, overprinting is quite frequent in viral genomes [21,22]. Indeed, the 22]. Indeed, the first evidence of overlapping genes came from the bacteriophage FX174 [23], first evidence of overlapping genes came from the bacteriophage ΦX174 [23], then fol- then followed by many examples in several eukaryotic viruses. Two theories have been lowed by many examples in several eukaryotic viruses. Two theories have been proposed proposed to explain the high abundance of overlapping genes in viral genomes [24]. The to explain the high abundance of overlapping genes in viral genomes [24]. The gene-com- gene-compression theory states that error-prone viral polymerases and biophysical con- pression theory states that error-prone viral polymerases and biophysical constraints im- straints imposed by the viral capsid drive the creation of overlapping genes that allow posed by the viral capsid drive the creation of overlapping genes that allow maximization maximization of the amount of information that can be encoded in small genomes [25]. The of the amount of information that can be encoded in small genomes [25]. The gene-novelty gene-novelty theory asserts that de novo creation of genes is driven by selective pressure, theory asserts that de novo creation of genes is driven by selective pressure, and gives rise and gives rise to gene products that provide a selective advantage to the virus, and thus to gene products that provide a selective advantage to the virus, and thus become fixed become fixed in the population [5]. in the Thepopulation high abundance [5]. of overlapping genes in viral genomes has allowed the use of statisticalThe high andabundance computational of overlapping methods genes to investigate in viral genomes the composition has allowed bias, the structural use of statisticalfeatures, and evolution, computational and potential methods function to investigate of overlapping the composition gene pairs bias, and structural de novo fea- pro- tures,teins evolution, [5,24,26,27 ].and Sequence potential composition function of overlapping varies greatly gene between pairs and overlapping de novo proteins and non- [5,24,26,27].overlapping Sequence genes, as composition well as between varies ancestral greatly and between novel overlapping genes in overlapping and non-overlap- pairs [27]. pingPavesi genes, et al. as showedwell as between that, in theancestral case of and overlapping novel genes pairs, in overlappi the codonng usagepairs [27]. of ancestral Pavesi etgenes al. showed is more that, similar in the to case the restof overlapping of the genome pairs, than the that codon of novel usage genes of ancestral [26]. While genes this is moredifference similar decreases to the rest with of thethe agegenome of de than novo th genesat of [novel6], constraints genes [26]. imposed While bythis the difference ancestral decreasesgene might with prevent the age the of novel de novo gene genes from [6], acquiring constraints a codon imposed usage by completely the ancestral similar gene to mightthat of prevent the rest the of thenovel genome gene from [26].
Recommended publications
  • Herpes Simplex Virus Type 1 Oril Is Not Required for Virus Infection In
    JOURNAL OF VIROLOGY, Nov. 1987, p. 3528-3535 Vol. 61, No. 11 0022-538X/87/113528-08$02.00/0 Copyright C 1987, American Society for Microbiology Herpes Simplex Virus Type 1 oriL Is Not Required for Virus Replication or for the Establishment and Reactivation of Latent Infection in Mice MARYELLEN POLVINO-BODNAR, PAULO K. ORBERG, AND PRISCILLA A. SCHAFFER* Laboratory of Tumor Virus Genetics, Dana-Farber Cancer Institute, and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115 Received 11 May 1987/Accepted 31 July 1987 During the course of experiments designed to isolate deletion mutants of herpes simplex virus type 1 in the gene encoding the major DNA-binding protein, ICP8, a mutant, d61, that grew efficiently in ICP8-expressing Vero cells but not in normal Vero cells was isolated (P. K. Orberg and P. A. Schaffer, J. Virol. 61:1136-1146, 1987). d61 was derived by cotransfection of ICP8-expressing Vero cells with infectious wild-type viral DNA and a plasmid, pDX, that contains an engineered 780-base-pair (bp) deletion in the ICP8 gene, as well as a spontaneous -55-bp deletion in OriL. Gel electrophoresis and Southern blot analysis indicated that d61 DNA carried both deletions present in pDX. The ability of d61 to replicate despite the deletion in OriL suggested that a functional OriL is not essential for virus replication in vitro. Because d61 harbored two mutations, a second mutant, ts+7, with a deletion in oriL-associated sequences and an intact ICP8 gene was constructed. Both d61 and ts+7 replicated efficiently in their respective permissive host cells, although their yields were slightly lower than those of control viruses with intact oriL sequences.
    [Show full text]
  • Topological Analysis of the Gp41 MPER on Lipid Bilayers Relevant to the Metastable HIV-1 Envelope Prefusion State
    Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state Yi Wanga,b, Pavanjeet Kaurc,d, Zhen-Yu J. Sune,1, Mostafa A. Elbahnasawya,b,2, Zahra Hayatic,d, Zhi-Song Qiaoa,b,3, Nhat N. Buic, Camila Chilea,b,4, Mahmoud L. Nasre,5, Gerhard Wagnere, Jia-Huai Wanga,f, Likai Songc, Ellis L. Reinherza,b,6, and Mikyung Kima,g,6 aLaboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; bDepartment of Medicine, Harvard Medical School, Boston, MA 02115; cNational High Magnetic Field Laboratory, Florida State University, Tallahassee, FL 32306; dDepartment of Physics, Florida State University, Tallahassee, FL 32306; eDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; fDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215; and gDepartment of Dermatology, Harvard Medical School, Boston, MA 02215 Edited by Peter Palese, Icahn School of Medicine at Mount Sinai, New York, NY, and approved September 23, 2019 (received for review July 18, 2019) The membrane proximal external region (MPER) of HIV-1 envelope immunologically vulnerable epitopes targeted by several of the most glycoprotein (gp) 41 is an attractive vaccine target for elicitation of broadly neutralizing antibodies (bNAbs) developed during the broadly neutralizing antibodies (bNAbs) by vaccination. However, course of natural HIV-1 infection (10–13). Insertion, deletion, current details regarding the quaternary structural organization of and mutations of residues in the MPER defined the functional the MPER within the native prefusion trimer [(gp120/41)3] are elu- importance of the MPER in Env incorporation, viral fusion, and sive and even contradictory, hindering rational MPER immunogen infectivity (14–16).
    [Show full text]
  • Viroporins: Structures and Functions Beyond Cell Membrane Permeabilization
    Editorial Viroporins: Structures and Functions beyond Cell Membrane Permeabilization José Luis Nieva 1,* and Luis Carrasco 2,* Received: 17 September 2015 ; Accepted: 21 September 2015 ; Published: 29 September 2015 Academic Editor: Eric O. Freed 1 Biophysics Unit (CSIC, UPV/EHU) and Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), P.O. Box 644, 48080 Bilbao, Spain 2 Centro de Biología Molecular Severo Ochoa (CSIC, UAM), c/Nicolás Cabrera, 1, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain * Correspondence: [email protected] (J.L.N.); [email protected] (L.C.); Tel.: +34-94-601-3353 (J.L.N.); +34-91-497-8450 (L.C.) Viroporins represent an interesting group of viral proteins that exhibit two sets of functions. First, they participate in several viral processes that are necessary for efficient production of virus progeny. Besides, viroporins interfere with a number of cellular functions, thus contributing to viral cytopathogenicity. Twenty years have elapsed from the first review on viroporins [1]; since then several reviews have covered the advances on viroporin structure and functioning [2–8]. This Special Issue updates and revises new emerging roles of viroporins, highlighting their potential use as antiviral targets and in vaccine development. Viroporin structure. Viroporins are usually short proteins with at least one hydrophobic amphipathic helix. Homo-oligomerization is achieved by helix–helix interactions in membranes rendering higher order structures, forming aqueous pores. Progress in viroporin structures during the last 2–3 years has in some instances provided a detailed knowledge of their functional architecture, including the fine definition of binding sites for effective inhibitors.
    [Show full text]
  • How Influenza Virus Uses Host Cell Pathways During Uncoating
    cells Review How Influenza Virus Uses Host Cell Pathways during Uncoating Etori Aguiar Moreira 1 , Yohei Yamauchi 2 and Patrick Matthias 1,3,* 1 Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; [email protected] 2 Faculty of Life Sciences, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK; [email protected] 3 Faculty of Sciences, University of Basel, 4031 Basel, Switzerland * Correspondence: [email protected] Abstract: Influenza is a zoonotic respiratory disease of major public health interest due to its pan- demic potential, and a threat to animals and the human population. The influenza A virus genome consists of eight single-stranded RNA segments sequestered within a protein capsid and a lipid bilayer envelope. During host cell entry, cellular cues contribute to viral conformational changes that promote critical events such as fusion with late endosomes, capsid uncoating and viral genome release into the cytosol. In this focused review, we concisely describe the virus infection cycle and highlight the recent findings of host cell pathways and cytosolic proteins that assist influenza uncoating during host cell entry. Keywords: influenza; capsid uncoating; HDAC6; ubiquitin; EPS8; TNPO1; pandemic; M1; virus– host interaction Citation: Moreira, E.A.; Yamauchi, Y.; Matthias, P. How Influenza Virus Uses Host Cell Pathways during 1. Introduction Uncoating. Cells 2021, 10, 1722. Viruses are microscopic parasites that, unable to self-replicate, subvert a host cell https://doi.org/10.3390/ for their replication and propagation. Despite their apparent simplicity, they can cause cells10071722 severe diseases and even pose pandemic threats [1–3].
    [Show full text]
  • Assembly Lecture 11 Biology W3310/4310 Virology Spring 2014
    Assembly Lecture 11 Biology W3310/4310 Virology Spring 2014 “Anatomy is des.ny.” --SIGMUND FREUD All virions complete a common set of assembly reac3ons * common to all viruses common to many viruses ©Principles of Virology, ASM Press The structure of a virus parcle determines how it is formed ©Principles of Virology, ASM Press Assembly is dependent on host cell machinery • Cellular chaperones • Transport systems • Secretory pathway • Nuclear import and export machinery Concentrang components for assembly: Nothing happens fast in dilute solu1ons • Viral components oSen visible by light microscopy (‘factories’ or ‘inclusions’) • Concentrate proteins on internal membranes (poliovirus) • Negri bodies (rabies virus) Viral proteins have ‘addresses’ built into their structure • Membrane targeYng: Signal sequences, fa\y acid modificaons • Membrane retenYon signals • Nuclear localizaYon sequences (NLS) • Nuclear export signals 414 Localiza3on of viral proteins to the nucleus CHAPTER 12 Golgi apparatus Ribosome Rough endoplasmic reticulum Plasma membrane Py(VP1) + VP2/3 Ad hexon + 5 100 kDa Nuclear envelope: Outer nuclear membrane Inner nuclear membrane Nucleus Nuclear pore complex Mitochondrion Cytoskeleton: Influenza virus NP Intermediate filament Microtubule Actin filament bundle Extracellular matrix ©Principles of Virology, ASM Press Figure 12.1 Localization of viral proteins to the nucleus. The nucleus and major membrane-bound compartments of the cytoplasm, as well as components of the cytoskeleton, are illustrated schematically and not to scale. Viral proteins destined for the nucleus are synthesized by cytoplasmic polyribosomes, as illustrated for the infl uenza virus NP protein. They engage with the cytoplasmic face of the nuclear pore complex and are translocated into the nucleus by the protein import machinery of the host cell.
    [Show full text]
  • Ube1a Suppresses Herpes Simplex Virus-1 Replication
    viruses Article UBE1a Suppresses Herpes Simplex Virus-1 Replication Marina Ikeda 1 , Akihiro Ito 2, Yuichi Sekine 1 and Masahiro Fujimuro 1,* 1 Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan; [email protected] (M.I.); [email protected] (Y.S.) 2 Laboratory of Cell Signaling, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-75-595-4717 Academic Editors: Magdalena Weidner-Glunde and Andrea Lipi´nska Received: 7 November 2020; Accepted: 1 December 2020; Published: 4 December 2020 Abstract: Herpes simplex virus-1 (HSV-1) is the causative agent of cold sores, keratitis, meningitis, and encephalitis. HSV-1-encoded ICP5, the major capsid protein, is essential for capsid assembly during viral replication. Ubiquitination is a post-translational modification that plays a critical role in the regulation of cellular events such as proteasomal degradation, protein trafficking, and the antiviral response and viral events such as the establishment of infection and viral replication. Ub-activating enzyme (E1, also named UBE1) is involved in the first step in the ubiquitination. However, it is still unknown whether UBE1 contributes to viral infection or the cellular antiviral response. Here, we found that UBE1a suppressed HSV-1 replication and contributed to the antiviral response. The UBE1a inhibitor PYR-41 increased HSV-1 production. Immunofluorescence analysis revealed that UBE1a highly expressing cells presented low ICP5 expression, and vice versa. UBE1a inhibition by PYR-41 and shRNA increased ICP5 expression in HSV-1-infected cells.
    [Show full text]
  • HSV-1 Single-Cell Analysis Reveals the Activation of Anti-Viral And
    RESEARCH ARTICLE HSV-1 single-cell analysis reveals the activation of anti-viral and developmental programs in distinct sub-populations Nir Drayman1,2*, Parthiv Patel1,2, Luke Vistain1,2, Savas¸Tay1,2* 1Institute for Molecular Engineering, The University of Chicago, Chicago, United States; 2Institute for Genomics and Systems Biology, The University of Chicago, Chicago, United States Abstract Viral infection is usually studied at the population level by averaging over millions of cells. However, infection at the single-cell level is highly heterogeneous, with most infected cells giving rise to no or few viral progeny while some cells produce thousands. Analysis of Herpes Simplex virus 1 (HSV-1) infection by population-averaged measurements has taught us a lot about the course of viral infection, but has also produced contradictory results, such as the concurrent activation and inhibition of type I interferon signaling during infection. Here, we combine live-cell imaging and single-cell RNA sequencing to characterize viral and host transcriptional heterogeneity during HSV-1 infection of primary human cells. We find extreme variability in the level of viral gene expression among individually infected cells and show that these cells cluster into transcriptionally distinct sub-populations. We find that anti-viral signaling is initiated in a rare group of abortively infected cells, while highly infected cells undergo cellular reprogramming to an embryonic-like transcriptional state. This reprogramming involves the recruitment of b-catenin to the host nucleus and viral replication compartments, and is required for late viral gene expression and progeny production. These findings uncover the transcriptional differences in cells with variable infection outcomes and shed new light on the manipulation of host pathways by HSV-1.
    [Show full text]
  • HIV-1) CD4 Receptor and Its Central Role in Promotion of HIV-1 Infection
    MICROBIOLOGICAL REVIEWS, Mar. 1995, p. 63–93 Vol. 59, No. 1 0146-0749/95/$04.0010 Copyright q 1995, American Society for Microbiology The Human Immunodeficiency Virus Type 1 (HIV-1) CD4 Receptor and Its Central Role in Promotion of HIV-1 Infection STEPHANE BOUR,* ROMAS GELEZIUNAS,† AND MARK A. WAINBERG* McGill AIDS Centre, Lady Davis Institute-Jewish General Hospital, and Departments of Microbiology and Medicine, McGill University, Montreal, Quebec, Canada H3T 1E2 INTRODUCTION .........................................................................................................................................................63 RETROVIRAL RECEPTORS .....................................................................................................................................64 Receptors for Animal Retroviruses ........................................................................................................................64 CD4 Is the Major Receptor for HIV-1 Infection..................................................................................................65 ROLE OF THE CD4 CORECEPTOR IN T-CELL ACTIVATION........................................................................65 Structural Features of the CD4 Coreceptor..........................................................................................................65 Interactions of CD4 with Class II MHC Determinants ......................................................................................66 CD4–T-Cell Receptor Interactions during T-Cell Activation
    [Show full text]
  • HIV-1 Env Gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Wa- Ter, and Ion Interactions
    bioRxiv preprint doi: https://doi.org/10.1101/292326; this version posted March 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. HIV-1 Env gp41 Transmembrane Domain Dynamics are Modulated by Lipid, Wa- ter, and Ion Interactions L.R. Hollingsworth IV, J.A. Lemkul, D.R. Bevan, and A.M. Brown Running Title: gp41 trimer dynamics in a lipid membrane Keywords: molecular dynamics simulations, protein-membrane interactions, HIV-1 gp41, envelope glycoprotein 1 bioRxiv preprint doi: https://doi.org/10.1101/292326; this version posted March 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract The gp41 transmembrane domain (TMD) of the envelope glycoprotein (Env) of the human immunodeficiency virus (HIV) modulates the conformation of the viral enve- lope spike, the only druggable target on the surface of the virion. Understanding of TMD dynamics is needed to better probe and target Env with small molecule and antibody therapies. However, little is known about TMD dynamics due to difficulties in describing native membrane properties. Here, we performed atomistic molecular dynamics simula- tions of a trimeric, prefusion TMD in a model, asymmetric viral membrane that mimics the native viral envelope. We found that water and chloride ions permeated the mem- brane and interacted with the highly conserved arginine bundle, (R696)3, at the center of the membrane and influenced TMD stability by creating a network of hydrogen bonds and electrostatic interactions.
    [Show full text]
  • The SARS-Coronavirus Infection Cycle: a Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis
    International Journal of Molecular Sciences Review The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis Nicholas A. Wong * and Milton H. Saier, Jr. * Department of Molecular Biology, Division of Biological Sciences, University of California at San Diego, La Jolla, CA 92093-0116, USA * Correspondence: [email protected] (N.A.W.); [email protected] (M.H.S.J.); Tel.: +1-650-763-6784 (N.A.W.); +1-858-534-4084 (M.H.S.J.) Abstract: Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel epidemic strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus disease 2019 (COVID- 19), a global health crisis. Other epidemic Betacoronaviruses include the 2003 SARS-CoV-1 and the 2009 Middle East Respiratory Syndrome Coronavirus (MERS-CoV), the genomes of which, particularly that of SARS-CoV-1, are similar to that of the 2019 SARS-CoV-2. In this extensive review, we document the most recent information on Coronavirus proteins, with emphasis on the membrane proteins in the Coronaviridae family. We include information on their structures, functions, and participation in pathogenesis. While the shared proteins among the different coronaviruses may vary in structure and function, they all seem to be multifunctional, a common theme interconnecting these viruses. Many transmembrane proteins encoded within the SARS-CoV-2 genome play important roles in the infection cycle while others have functions yet to be understood. We compare the various structural and nonstructural proteins within the Coronaviridae family to elucidate potential overlaps Citation: Wong, N.A.; Saier, M.H., Jr.
    [Show full text]
  • Superimposition of Viral Protein Structures: a Means to Decipher the Phylogenies of Viruses
    viruses Review Superimposition of Viral Protein Structures: A Means to Decipher the Phylogenies of Viruses Janne J. Ravantti 1 , Ane Martinez-Castillo 2 and Nicola G.A. Abrescia 2,3,4,* 1 Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, FI-00014 Helsinki, Finland; Janne.Ravantti@helsinki.fi 2 Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, 48160 Derio, Spain; [email protected] 3 IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain 4 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-946572502 Received: 10 September 2020; Accepted: 2 October 2020; Published: 9 October 2020 Abstract: Superimposition of protein structures is key in unravelling structural homology across proteins whose sequence similarity is lost. Structural comparison provides insights into protein function and evolution. Here, we review some of the original findings and thoughts that have led to the current established structure-based phylogeny of viruses: starting from the original observation that the major capsid proteins of plant and animal viruses possess similar folds, to the idea that each virus has an innate “self”. This latter idea fueled the conceptualization of the PRD1-adenovirus lineage whose members possess a major capsid protein (innate “self”) with a double jelly roll fold. Based on this approach, long-range viral evolutionary relationships can be detected allowing the virosphere to be classified in four structure-based lineages. However, this process is not without its challenges or limitations.
    [Show full text]
  • Viral Surface Glycoproteins, Gp120 and Gp41, As Potential Drug Targets
    European Journal of Medicinal Chemistry 46 (2011) 979e992 Contents lists available at ScienceDirect European Journal of Medicinal Chemistry journal homepage: http://www.elsevier.com/locate/ejmech Invited review Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug Cátia Teixeira a,b,c, José R.B. Gomes b, Paula Gomes c,*, François Maurel a a ITODYS, Université Paris Diderot, CNRS e UMR7086, 15 Rue Jean Antoine de Baif, 75205 Paris Cedex 13, France b CICECO, Universidade de Aveiro, Campus Universitário de Santiago, P-3810-193 Aveiro, Portugal c Centro de Investigação em Química da Universidade do Porto, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, R. Campo Alegre, 687, P-4169-007 Porto, Portugal article info abstract Article history: The first anti-HIV drug, zidovudine (AZT), was approved by the FDA a quarter of a century ago, in 1985. Received 22 September 2010 Currently, anti-HIV drug-combination therapies only target HIV-1 protease and reverse transcriptase. Received in revised form Unfortunately, most of these molecules present numerous shortcomings such as viral resistances and 15 January 2011 adverse effects. In addition, these drugs are involved in later stages of infection. Thus, it is necessary to Accepted 25 January 2011 develop new drugs that are able to block the first steps of viral life cycle. Entry of HIV-1 is mediated by its Available online 3 February 2011 two envelope glycoproteins: gp120 and gp41. Upon gp120 binding to cellular receptors, gp41 undergoes a series of conformational changes from a non-fusogenic to a fusogenic conformation.
    [Show full text]